TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
TENAX THERAPEUTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026
$1.52+0.16 (+11.76%)
Close on Oct 19, 2026
- Market cap
- $77.32M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Jan 3, 2024 | 1-for-80 reverse | Earlier per-share figures multiplied by 80 |
| Jan 5, 2023 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Apr 2, 2018(first seen in filings) | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Feb 26, 2018 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Jun 26, 2013(first seen in filings) | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| May 13, 2013 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Nov 9, 2009 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |